W5R-22736-13180
3 vaccinations
3 coded responses
8 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 015 / MA
- Registered
- 2021-01-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-26
Dose 1 — Moderna
-
2021-01-26
Registered in v-safe
-
2021-01-26
Dose 2 — Moderna
-
2021-01-26
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-02-04
-
2021-02-11
Survey response — day 14, dose 2MedDRA: Pyrexia — Feeling: Good · Be unable to workFree text: Fever yesterday of 100.7poMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-22
Dose 3 — Moderna
-
2021-10-24
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
-
2022-04-22
Survey response — 6 months, dose 3MedDRA: Idiopathic intracranial hypertension — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Idiopathic intracranial hypertensionMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-28
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-22
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CovidMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-26 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-10-22 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-22 | Successful 2022-04-28 |
Participant prefers to complete VAERS report online |
Free text
Release 4 — day 14, dose 2
Symptoms: Fever yesterday of 100.7po
Release 11 — 6 months, dose 3
Symptoms: Idiopathic intracranial hypertension
Release 12 — 12 months, dose 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Idiopathic intracranial hypertension | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release